Clinical Trial Update: PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of oral and intravenous clofarabine in high-risk myelodysplastic syndrome and acute leukemias; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED